Biograph and Caristo begin US trial on AI heart disease detection

Biograph and Caristo Diagnostics announced the launch of what they describe as the first U.S. clinical study to explore AI-powered detection of coronary artery inflammation in asymptomatic patients, the companies said. The trial, open to Biograph’s high-tier “Black Tier” members who meet clinical eligibility, will use Caristo’s CaRi-Heart and CaRi-Plaque technologies on cardiac CT scans […] The post Biograph and Caristo begin US trial on AI heart disease detection appeared first on Longevity.Technology.